NCT04953312 2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
Clinical Trials
79 trialsNCT04565665 2026-03-10
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT05672355 2026-03-05
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 2 Recruiting
NCT07450833 2026-03-05
BOOST
Benfovir AG
Phase 1 Completed
NCT03830320 2026-02-27
Positron Emission Tomography (PET) Imaging of Thrombosis
Massachusetts General Hospital
Phase 1 Recruiting
NCT04977024 2026-02-11
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax, Inc.
Phase 2 Active not recruiting
NCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04421625 2025-12-30
PAPESCO-19
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT04442048 2025-12-30
COV-IMMUNO
Canadian Cancer Trials Group
Phase 3 Completed
NCT04425616 2025-12-02
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer
University Hospital Southampton NHS Foundation Trust
Phase NA Completed
NCT05102656 2025-11-17
Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04492410 2025-09-30
NEOSCREENCOVID
Centre Antoine Lacassagne
Phase NA Completed
NCT05120869 2025-09-04
Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention
University of Texas, El Paso
Phase NA Completed
NCT05655546 2025-08-08
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
Phase NA Terminated
NCT04870333 2025-06-20
PROTECT-V
Cambridge University Hospitals NHS Foundation Trust
Phase 2/3 Completed
NCT03305341 2025-06-11
COVSP-BCG
Medicine Invention Design, Inc
Phase EARLY_PHASE1 Active not recruiting
NCT04377659 2025-05-28
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT04347226 2025-05-22
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Columbia University
Phase 2 Terminated
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT05386355 2025-03-11
MoVeUP
IDeA States Pediatric Clinical Trials Network
Phase NA Completed
NCT05135650 2025-02-13
Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study
Fred Hutchinson Cancer Center
Phase 1 Terminated
NCT04466098 2025-01-29
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT06469138 2025-01-29
8479217
BerGenBio ASA
Phase 1 Completed
NCT04575064 2024-10-09
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
Klinikum Bremen-Mitte, gGmbH
Phase 2/3 Withdrawn
NCT05016622 2024-07-31
Booster Dose Trial
Montefiore Medical Center
Phase 2 Terminated
NCT04404361 2024-06-05
PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer
CTI BioPharma
Phase 2 Terminated
NCT04547634 2024-06-04
Telerehabilitation in Oncology Patients
University of Malaga
Phase NA Unknown
NCT04715438 2024-05-03
VOICE
University Medical Center Groningen
Phase NA Active not recruiting
NCT04426201 2024-04-11
ILIAD-7-US-O
Revimmune
Phase 2 Terminated
NCT05465876 2024-04-04
PACE-CLL
Sunnybrook Health Sciences Centre
Phase 2 Withdrawn
NCT04487639 2024-02-16
FERTICOVID
University Hospital, Clermont-Ferrand
Phase NA Completed
NCT05125562 2024-02-13
Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19
Direct Biologics, LLC
Phase 2 Withdrawn
NCT05075538 2024-01-17
I-SPARC
Jules Bordet Institute
Phase 4 Terminated
NCT04358406 2023-11-28
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Phase 2 Completed
NCT04805203 2023-10-19
Covimmunomm
Intergroupe Francophone du Myelome
Phase NA Terminated
NCT05080920 2023-09-21
OnCOVInf
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
Phase NA Completed
NCT05303376 2023-09-13
Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness
Immune Biosolutions Inc
Phase 1/2 Completed
NCT05438498 2023-09-08
Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2
MediMergent, LLC
Phase 3 Terminated
NCT04534725 2023-08-24
C-SMART
Peter MacCallum Cancer Centre, Australia
Phase 3 Completed
NCT05855395 2023-07-12
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Huashan Hospital
Phase NA Unknown
NCT05018078 2023-06-27
Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer
Beijing 302 Hospital
Phase NA Unknown
NCT04397614 2023-04-24
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
University of Oklahoma
Phase NA Completed
NCT05393999 2023-04-24
SABRE
Imperial College Healthcare NHS Trust
Phase 2 Withdrawn
NCT05753228 2023-03-03
In Vivo Investigation on Mitochondrial Dysfunction in Post-COVID Fatigue and Cancer Fatigue.
National University Hospital, Singapore
Phase NA Unknown
NCT04548531 2023-02-22
Engaging Patients in Colon Cancer Screening Decisions During COVID-19
Massachusetts General Hospital
Phase NA Completed
NCT04844489 2023-02-06
COVIVAC-ID
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT04733833 2023-02-01
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Vascular Biogenics Ltd. operating as VBL Therapeutics
Phase 2 Completed
NCT05371275 2022-11-07
CDK6COV
biotx.ai GmbH
Phase 2 Withdrawn
NCT04333914 2022-09-30
IMMUNONCOVID
Centre Leon Berard
Phase 2 Completed
NCT04447235 2022-08-09
TITAN
Instituto do Cancer do Estado de São Paulo
Phase 2 Terminated